The White House recently announced a deal with two pharmaceutical manufacturers to lower the price of GLP-1 drugs for weight loss.

Two manufacturers, Eli Lilly and Novo Nordisk, agreed to lower the prices of their drugs from upwards of $1,000 a month to around $350 a month when purchased through TrumpRx, the White House said on Nov. 6. In exchange, the Trump administration said it will allow Medicare to cover the drugs for some patients. This government-funded health plan hasn't previously covered GLP-1s for weight loss. 

While the agreements won’t directly affect most employer-sponsored health plans, they could have secondary effects for companies that are covering the pricey drugs.

For more on what Trump’s GLP-1 deal means for workplace coverage, keep reading here.—CV

During the holidays, you have to interact with relatives you’d rather avoid. During the course of business, CHROs have to interact with leaders they’d rather avoid. At least, that’s the case for some HR leaders and their company’s board members.

The CHRO’s C-suite clout has risen in recent years thanks to the challenges brought on by and following the pandemic. Their role has been extra critical in 2025: 79% of the 300 director-level or higher HR leaders surveyed by executive search firm DSG Global and Harris Poll said the CHRO role is rising in importance at their organization, amid the increasingly complex political and business environment.

At the same time, HR leaders reported headaches dealing with their company’s board. Nearly two-thirds (61%) of respondents believe their corporate board has too much power over their talent strategy. Another 51% said their board’s expanded role in talent strategy is a major pain point for their organization.

HR leaders should view the board’s interest in talent strategy as an opportunity to strengthen their relationships with its members, Aileen Alexander, DSG Global’s CEO, told HR Brew.

For more on why increased board interest in talent strategy is good for HR, keep reading here.—PM

Business executives are still prioritizing and pushing forward sustainability initiatives, according to a recent Deloitte survey, despite reduced pressure from shareholders on, and increased hostility from the Trump administration to, ESG initiatives.

In a survey of more than 2,100 C-suite executives, Deloitte found that for the fourth consecutive year, sustainability remained a top business priority. For 45% of respondents, sustainability and climate change ranked among the top three challenges, along with technology adoption and AI. And 83% of respondents told Deloitte that their organizations increased sustainability investments in the last year.

Implementing new technology solutions to support sustainability goals was executives’ top priority.

For more on the business case for sustainability, keep reading on CFO Brew.—JK

The world of work is changing faster than ever. On Dec. 3, HR Brew and Deel explore how global leaders are shaping policies and strategies to make that change equitable, sustainable, and full of opportunity for all.

More focus, less fluff. CollabWORK filters out the noise and delivers jobs that actually match what HR Brew readers are looking for. Click here to see the full board of curated roles.